Göttingen, Germany, May 16-17, 2024 — The Eurolife Network, a leading consortium of European academic institutions dedicated to advancing health sciences, proudly celebrated its 25th anniversary with a landmark summit in Göttingen, Germany. The summit, held at Universitätsmedizin Göttingen, showcased a rich legacy of impactful collaboration and academic excellence that has defined Eurolife over the past quarter-century.

The highlight of the celebration was the Eurolife Semi-Annual Academic Symposium, which focused on “Advanced Therapies for Cardiovascular Disease.” This symposium brought together eminent experts from three of Eurolife’s prestigious partner institutions, who shared groundbreaking insights into the latest advancements in cardiovascular treatment and research.

The distinguished speakers included:

• Prof. Wolfram-Hubertus Zimmermann, Director of the Institute of Pharmacology at Universitätsmedizin Göttingen, who offered a comprehensive overview of innovative pharmacological approaches to cardiovascular therapy with insights into the reconstruction of functional myocardium using stem cell-based tissue engineering.

• Prof. Andrew H Baker, a leading authority in Translational Cardiovascular Sciences from the University of Edinburgh, who discussed the potential of translational research in bridging the gap between laboratory discoveries and clinical applications in cardiovascular medicine.

• Prof. Marie-José Goumans, an expert in Molecular Cardiovascular Cell Biology at Leiden University Medical Center, who explored cutting-edge developments in cell-based therapies for treating heart diseases.

The speakers were proudly welcomed into the prestigious circle of Eurolife Distinguished Lecturers, receiving the esteemed Eurolife Medals, awarded by the Eurolife Chair – Prof. Christine Bandtlow, in honor of their exceptional contributions and dedication to advancing research.

The presentations sparked enthusiastic discussions and numerous thought-provoking questions from the audience, underscoring the dynamic and interactive nature of the event. This symposium not only highlighted the impressive expertise within the Eurolife network but also reinforced the collaborative spirit that has driven its success over the last 25 years.

Founded in 1999, the Eurolife Network has grown into a robust alliance of leading European universities and medical institutions. It has consistently championed cross-border academic partnerships, facilitating research and education initiatives that address some of the most pressing challenges in health sciences today, i.e. ethical considerations of Biomedical Big Data handling and use – DATAETHICS.

As Eurolife looks ahead, it remains committed to fostering innovation, sharing knowledge, and promoting excellence in healthcare research and education. The Göttingen summit and the symposium on advanced cardiovascular therapies exemplify Eurolife’s ongoing dedication to driving forward the frontiers of medical science through collaboration.